Petryshak, Bohdan
Iljin, Mikhail
Denissova, Alina
Ariva, Joonas
Häide, Toomas
Lasn, Veljo
Reim, Martin
Ivaniv, Ihor
Lillsaar, Toomas
Vilt, Hardi
Leht, Anu
Karask, Anti
Kiudma, Gitana
Käpp, Rait
Salumaa, Priit
Ilves, Pilvi
Fishman, Dmytro https://orcid.org/0000-0002-4644-8893
Funding for this research was provided by:
Better Medicine OÜ
Article History
Received: 21 April 2025
Accepted: 13 November 2025
First Online: 27 November 2025
Competing interests
: Bohdan Petryshak, Dmytro Fishman, Martin Reim, and Priit Salumaa are employees and co-founders, and therefore shareholders, of Better Medicine, the company that sponsored this research. Three out of these four (except Dmytro Fishman) have received salaries from Better Medicine. Mikhail Iljin, Toomas Häide, Veljo Lasn, Alina Denissova, and Ihor Ivaniv are employees or ex-employees of Better Medicine. Rait Käpp is a consultant for Better Medicine. Joonas Ariva is a PhD student at the University of Tartu, working on a research project sponsored by Better Medicine. Martin Reim, Alina Denissova, Toomas Lillsaar, Hardi Vilt, Anu Leht, Anti Karask, Gitana Kiudma, and Pilvi Ilves are employees of TUK, which has received research funding from Better Medicine for this project.